|

GENE THERAPY
THE STATE OF THE ART
Dr. Abdel Aziz El Bayoumi
Professor of Genetics
Dr. Khalid Al Ali
Lecturer of Genetics
Department of Biological Sciences
University of Qatar, Doha
|
|
5.7 T-Cells
The T-cells of the individual are removed from the patient, then placed in tissue culture
stimulated to proliferate, by treating them with the lymphokine, Interlekin 2(1L-2), then
infected with the retroviral vector. Finally, they reinfected to the child.
The infection has to be repeated because T-cells live for only 6-12 months in the
blood.
|